140 related articles for article (PubMed ID: 35234319)
1. A clinicopathologic and molecular analysis of five cases of bronchiolar adenoma with rare mutations.
Takeda-Miyata N; Miyagawa-Hayashino A; Hamada S; Nagamine M; Fujii T; Imura T; Tsunezuka H; Shimomura M; Yamaguchi T; Yanada M; Inoue M; Konishi E
Pathol Int; 2022 May; 72(5):273-282. PubMed ID: 35234319
[TBL] [Abstract][Full Text] [Related]
2. Bronchiolar Adenoma: Expansion of the Concept of Ciliated Muconodular Papillary Tumors With Proposal for Revised Terminology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 Cases.
Chang JC; Montecalvo J; Borsu L; Lu S; Larsen BT; Wallace WD; Sae-Ow W; Mackinnon AC; Kim HR; Bowman A; Sauter JL; Arcila ME; Ladanyi M; Travis WD; Rekhtman N
Am J Surg Pathol; 2018 Aug; 42(8):1010-1026. PubMed ID: 29846186
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma.
Higashiyama M; Motoi N; Yotsukura M; Yoshida Y; Nakagawa K; Yagishita S; Shirasawa M; Yoshida T; Shiraishi K; Kohno T; Ohe Y; Watanabe SI
Pathol Int; 2023 May; 73(5):188-197. PubMed ID: 36896472
[TBL] [Abstract][Full Text] [Related]
4. So-called "non-classic" ciliated muconodular papillary tumors: a comprehensive comparison of the clinicopathological and molecular features with classic ciliated muconodular papillary tumors.
Zheng Q; Luo R; Jin Y; Shen X; Shan L; Shen L; Hou Y; Li Y
Hum Pathol; 2018 Dec; 82():193-201. PubMed ID: 30092236
[TBL] [Abstract][Full Text] [Related]
5. Bronchiolar adenoma/ciliated muconodular papillary tumor mixed with adenocarcinoma in situ in the same tumor.
Uchiyama S; Mizutani K; Suzuki E; Yoshii N; Watanabe T; Tsuchida H; Yobita S; Iguchi K; Nakamura M; Endo T; Takahashi S; Ogawa H; Tanahashi M
Thorac Cancer; 2023 Feb; 14(4):427-431. PubMed ID: 36578104
[TBL] [Abstract][Full Text] [Related]
6. Bronchiolar Adenoma/Pulmonary Ciliated Muconodular Papillary Tumor.
Shirsat H; Zhou F; Chang JC; Rekhtman N; Saqi A; Argyropoulos K; Azour L; Simms A; Melamed J; Hung YP; Roden AC; Mino-Kenudson M; Moreira AL; Narula N
Am J Clin Pathol; 2021 May; 155(6):832-844. PubMed ID: 33313677
[TBL] [Abstract][Full Text] [Related]
7. Ciliated muconodular papillary tumor/bronchiolar adenoma of the lung.
Kao TH; Yeh YC
Semin Diagn Pathol; 2021 Sep; 38(5):62-71. PubMed ID: 33985833
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
Villaruz LC; Socinski MA; Abberbock S; Berry LD; Johnson BE; Kwiatkowski DJ; Iafrate AJ; Varella-Garcia M; Franklin WA; Camidge DR; Sequist LV; Haura EB; Ladanyi M; Kurland BF; Kugler K; Minna JD; Bunn PA; Kris MG
Cancer; 2015 Feb; 121(3):448-56. PubMed ID: 25273224
[TBL] [Abstract][Full Text] [Related]
9. Distal-type bronchiolar adenoma of the lung harboring an EGFR exon 21 p.L858R mutation: A case report.
Yang C; Wang X; Da J; Ma K
Thorac Cancer; 2020 Dec; 11(12):3596-3598. PubMed ID: 33063939
[TBL] [Abstract][Full Text] [Related]
10. Morphological, immunohistochemical, and genetic analyses of bronchiolar adenoma and its putative variants.
Shao J; Yin JC; Bao H; Zhao R; Han Y; Zhu L; Wu X; Shao Y; Zhang J
J Pathol Clin Res; 2021 May; 7(3):287-300. PubMed ID: 33400370
[TBL] [Abstract][Full Text] [Related]
11. Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation.
Udo E; Furusato B; Sakai K; Prentice LM; Tanaka T; Kitamura Y; Tsuchiya T; Yamasaki N; Nagayasu T; Nishio K; Fukuoka J
Diagn Pathol; 2017 Aug; 12(1):62. PubMed ID: 28830562
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristic of ciliated muconodular papillary tumour of the lung.
Yang Y; Xie X; Jiang G; Zhang L; Liu H
J Clin Pathol; 2022 Feb; 75(2):128-132. PubMed ID: 33722842
[TBL] [Abstract][Full Text] [Related]
13. First case of bronchiolar adenoma lined purely by mucinous luminal cells with molecular analysis: A case report.
Liu S; Liu N; Xiao M; Wang L; Wang EH
Medicine (Baltimore); 2020 Sep; 99(39):e22322. PubMed ID: 32991441
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.
Ohba T; Toyokawa G; Osoegawa A; Hirai F; Yamaguchi M; Taguchi K; Seto T; Takenoyama M; Ichinose Y; Sugio K
Surg Today; 2016 Sep; 46(9):1091-8. PubMed ID: 26711128
[TBL] [Abstract][Full Text] [Related]
15. Frequent EGFR exon 20 insertion in the so-called peripheral-type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under-recognised entity?
Zheng Q; Hou L; Shang G; Qi X; Zhang M; Jin Y; Wang Y; Xue Q; Wu C; Li Y
Histopathology; 2023 Aug; 83(2):178-192. PubMed ID: 36864007
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary peripheral glandular papilloma and mixed squamous cell and glandular papilloma frequently harbour the BRAF V600E mutation.
Lin DL; Xing XM; Ran WW; Zhao H; Li GQ; Xu J; Wang Y; Shao SH; Wang JG
Histopathology; 2020 Jun; 76(7):997-1004. PubMed ID: 32096885
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations.
Kinno T; Tsuta K; Shiraishi K; Mizukami T; Suzuki M; Yoshida A; Suzuki K; Asamura H; Furuta K; Kohno T; Kushima R
Ann Oncol; 2014 Jan; 25(1):138-42. PubMed ID: 24297085
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
Chen LF; Chen XY; Yu XB
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):221-5. PubMed ID: 27033383
[TBL] [Abstract][Full Text] [Related]
19. PCR-based detection of EGFR, ALK, KRAS and BRAF mutations in Russian patients with lung adenocarcinoma: a single-center experience.
Mitiushkina NV; Kholmatov MM; Venina AR; Tiurin VI; Yanus GA; Sokolova TN; Yatsuk OS; Zaitseva OA; Ivantsov AO; Kuligina ES; Togo AV; Imyanitov EN
Neoplasma; 2018 Nov; 65(6):972-979. PubMed ID: 30334450
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status.
Wang J; Dong Y; Cai Y; Zhou L; Wu S; Liu G; Su D; Li X; Qin N; Nong J; Jia H; Zhang Q; Mu J; Zeng X; Zhang H; Zhang S; Zhang Z
J Cancer Res Clin Oncol; 2014 Mar; 140(3):453-60. PubMed ID: 24442099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
